X4 Pharmaceuticals Inc.

09/17/2025 | Press release | Distributed by Public on 09/18/2025 04:04

Notice of Effectiveness (Form EFFECT)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 17, 2025 4:15 P.M.
Form: S-3
CIK: 0001501697
Company Name: X4 Pharmaceuticals, Inc
File Number: 333-290158
X4 Pharmaceuticals Inc. published this content on September 17, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on September 18, 2025 at 10:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]